Richard Braverman
- Molecular Biology top 10%
- Cell Biology top 5%
- Physiology
- Oncology
- Biochemistry top 5%
- Co-authors
- Herbert L. CooperWilliam C. VassJ.E. FolkB SaferDouglas R. LowyAlex G. PapageorgeXiaolan QianLaura Asnaghi
- Topics
- RNA modifications and cancer (3 papers)RNA and protein synthesis mechanisms (3 papers)Tuberous Sclerosis Complex Research (2 papers)
- Partner nations
- United StatesIndiaNetherlands
In The Last Decade
Richard Braverman
17 papers receiving 964 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 772
- Cell Biology 248
- Physiology 166
- Oncology 127
- Biochemistry 95
Countries citing papers authored by Richard Braverman
This map shows the geographic impact of Richard Braverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Braverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Braverman more than expected).
Fields of papers citing papers by Richard Braverman
This network shows the impact of papers produced by Richard Braverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Braverman. The network helps show where Richard Braverman may publish in the future.
Co-authorship network of co-authors of Richard Braverman
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Braverman. A scholar is included among the top collaborators of Richard Braverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Braverman. Richard Braverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 42 | |
| 2 | 61 | |
| 3 | 147 | |
| 4 | 9 | |
| 5 | 203 | |
| 6 | 24 | |
| 7 | 20 | |
| 8 | 32 | |
| 9 | 19 | |
| 10 | 49 | |
| 11 | 55 | |
| 12 | 184 | |
| 13 | 19 | |
| 14 | 11 | |
| 15 | 45 | |
| 16 | 35 | |
| 17 | 41 |
About Richard Braverman
Richard Braverman is a scholar working on Cell Biology, Molecular Biology and Immunology and Allergy, having authored 17 papers that have together received 996 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Tuberous Sclerosis Complex Research (2 papers). The work is most often cited by research in Cell Biology (248 citations), Biochemistry (95 citations) and Molecular Biology (772 citations). Richard Braverman has collaborated with scholars based in United States, India and Netherlands. Frequent co-authors include Herbert L. Cooper, William C. Vass, J.E. Folk, B Safer, Douglas R. Lowy, Alex G. Papageorge, Xiaolan Qian, Laura Asnaghi, Shaowei Li and Jeffrey E. DeClue. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.